1 November 2024 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZenecas China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down…
This announcement contains inside information
30 October 2024
AstraZeneca China President currently under investigation
Leon Wang, Executive Vice President International and AstraZeneca China…
The CHMP recommends approval for AZNs Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.…
21 October 2024
Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated…
Although CSL Behring’s Hizentra (IgPro20) is touted as a key pipeline agent to watch, rheumatologists currently prefer AstraZeneca’s Saphnelo (anifrolumab),…
AstraZeneca, Accenture, AT&T and National Presto Industries are part of the Zacks top Analyst Blog.…
Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Accenture plc (ACN) and AT&T…
…
7 October 2024
AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy
AstraZeneca has entered into an exclusive…
…
London, UK, 7 October 2024 – Avillion Life Sciences Ltd (“Avillion”) announces that the ongoing BATURA Phase IIIb trial evaluating…
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN),…
The FDA grants priority review to AZNs sNDA for Calquence for untreated mantle cell lymphoma. A decision is expected in…
1 October 2024 15:00 BST
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
The FDA grants priority review to AZNs sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer. A decision…
European health-care stocks are set to snap their longest winning streak since March 2010, dragged down by concerns over Novo…
Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products are part of the Zacks top Analyst Blog.…
26 September 2024
Tagrisso approved in the US for patients with
unresectable, Stage III EGFR-mutated lung cancer
Based on LAURA Phase III trial results which showed Tagrisso
extended…
Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.…
Todays Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC (AZN) and…
AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates with…
The FDA approves AstraZenecas Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.…
…
1. Rightmove receives third bid from genuinely disappointed REA Group This marks the third approach made by REA, following an…
23 September 2024
Datopotamab deruxtecan final overall survival results reported in
patients with metastatic HR-positive, HER2-low or negative breast cancer in
TROPION-Breast01 Phase…
US FDA approves AstraZenecas flu vaccine for self-administration…
FDA approves Lillys eczema drug, Ebglyss, and the expanded use of Novartis Kisqali, Mercks Keytruda and AstraZenecas Fasenra.…
BenevolentAI (OTC:BAIVF), the AI-driven biopharma drug discovery working with the likes of AstraZeneca and Merck, today announced its interim results…
Thermo Fisher Scientific will expand its bioanalytical presence in Europe and has chosen Gothenburg, Sweden, as a base for its…
18 September 2024
Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
New indication supported by the MANDARA trial which showed…
The FDA okays AstraZenecas Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the second approved indication for…
…
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…
Die Astrazeneca-Aktie gerät unter Druck, nachdem die Deutsche Bank Research ihre Einschätzung von "Halten" auf "Verkaufen" herabgestuft und das Kursziel…
AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the…
FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft…
Wien (www.aktiencheck.de) - Rating-Update:
Hans Engel, Analyst von Erste Group Research, stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455,…
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft und das Kursziel von 11000 auf…
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft und das Kursziel von 11000…
Stockholm (www.aktiencheck.de) - Rating-Update:
Die Analysten von Nordea stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…
…
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 15914 Pence…
Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug…
The FTSE 100 dipped on Tuesday as AstraZeneca weighed on the index after announcing disappointing developments for a lung cancer…
AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees…
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant…
AstraZeneca shares down on disappointing drug trial results…
FTSE 100 falls as AstraZeneca weighs; slowing wage growth cements rate cut bets…
European shares hold ground as AstraZeneca drags, tech shares rise…